5-Bromo-1-ethyl-1H-1,2,3-triazole

Catalog No.: 
ACZNAA175
CAS No.: 
1393560-22-9
Molecular Formula: 
C4H6BrN3
Molecular Weight: 
176.02
5-Bromo-1-ethyl-1H-1,2,3-triazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$243.00InquiryInquiry
100mg95%$350.00InquiryInquiry
250mg95%$491.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Bromo-1-ethyl-1H-1,2,3-triazole
IUPAC Name5-bromo-1-ethyl-1H-1,2,3-triazole
Molecular FormulaC4H6BrN3
Molecular Weight176.02
SMILESCCN1N=NC=C1Br
InChI KeyZFBVKTONEWDMNO-UHFFFAOYSA-N
Synonym1H-1,2,3-Triazole, 5-bromo-1-ethyl-;5-bromo-1-ethyl-1H-1,2,3-triazole
CAS No.1393560-22-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACZNAA175 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLIVG691 route compound structure diagram
    ACLIVG69140964-56-5In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZNAA175 route product structure diagram
    ACZNAA1751393560-22-9
Inquiry

2. ACZNAA175 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLIVG691 route compound structure diagram
    ACLIVG69140964-56-5In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZNAA175 route product structure diagram
    ACZNAA1751393560-22-9
Inquiry

3. ACZNAA175 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZNAA175 route product structure diagram
    ACZNAA1751393560-22-9
Inquiry

Comments (0)